Repro-Med Systems, Inc. (OTCMKTS:REPR) Director Joseph M. Jr. Manko bought 64,039 shares of the stock in a transaction dated Wednesday, September 12th. The shares were bought at an average cost of $1.44 per share, with a total value of $92,216.16. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.

Shares of OTCMKTS:REPR traded down $0.01 during trading on Thursday, hitting $1.43. 200 shares of the company traded hands, compared to its average volume of 23,048. Repro-Med Systems, Inc. has a one year low of $0.46 and a one year high of $1.50.

Repro-Med Systems (OTCMKTS:REPR) last posted its earnings results on Monday, August 6th. The company reported $0.01 EPS for the quarter. The company had revenue of $4.50 million for the quarter.

Repro-Med Systems Company Profile

Repro Med Systems, Inc designs, manufactures, and markets proprietary portable medical devices and supplies primarily for the ambulatory infusion market and emergency medical applications worldwide. The company offers mechanical infusion product FREEDOM infusion systems, which include the FREEDOM60 syringe infusion driver, the FreedomEdge syringe infusion driver, HIgH-Flo subcutaneous safety needle sets, RMS precision flow rate tubing, and RMS precision flow rate controller, as well as medical suction product RES-Q-VAC, a portable medical suction system.

Read More: Marijuana Stocks Investing Considerations

Insider Buying and Selling by Quarter for Repro-Med Systems (OTCMKTS:REPR)

Receive News & Ratings for Repro-Med Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Repro-Med Systems and related companies with's FREE daily email newsletter.